Mark Gompels

8.2k total citations
89 papers, 2.7k citations indexed

About

Mark Gompels is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Mark Gompels has authored 89 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 27 papers in Epidemiology and 23 papers in Virology. Recurrent topics in Mark Gompels's work include HIV/AIDS Research and Interventions (34 papers), HIV/AIDS drug development and treatment (25 papers) and HIV Research and Treatment (23 papers). Mark Gompels is often cited by papers focused on HIV/AIDS Research and Interventions (34 papers), HIV/AIDS drug development and treatment (25 papers) and HIV Research and Treatment (23 papers). Mark Gompels collaborates with scholars based in United Kingdom, United States and Australia. Mark Gompels's co-authors include R J Lock, Sarah Johnston, Claire Bethune, Caroline Sabin, Margaret May, Margaret Johnson, Richard Gilson, David R. Tomlinson, Chloe Orkin and Amy Price and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Neurology.

In The Last Decade

Mark Gompels

85 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Gompels United Kingdom 24 837 595 516 494 442 89 2.7k
David M. Aboulafia United States 37 598 0.7× 1.1k 1.8× 373 0.7× 340 0.7× 282 0.6× 174 4.3k
A J Pinching United Kingdom 30 709 0.8× 907 1.5× 199 0.4× 558 1.1× 422 1.0× 59 3.0k
Aman Sharma India 36 909 1.1× 812 1.4× 308 0.6× 971 2.0× 145 0.3× 383 4.9k
Joseph A. Church United States 30 826 1.0× 577 1.0× 213 0.4× 255 0.5× 808 1.8× 182 3.2k
A Sobel France 24 741 0.9× 493 0.8× 193 0.4× 119 0.2× 527 1.2× 59 1.8k
Tim Niehues Germany 31 525 0.6× 598 1.0× 384 0.7× 213 0.4× 117 0.3× 153 3.3k
Robert P. Nelson United States 26 386 0.5× 490 0.8× 219 0.4× 352 0.7× 201 0.5× 97 2.7k
A Levine United States 25 417 0.5× 849 1.4× 263 0.5× 126 0.3× 289 0.7× 45 2.7k
Maëlenn Gouillou France 21 274 0.3× 370 0.6× 122 0.2× 256 0.5× 336 0.8× 43 1.5k
Aziza Shad United States 24 602 0.7× 526 0.9× 211 0.4× 198 0.4× 186 0.4× 48 2.7k

Countries citing papers authored by Mark Gompels

Since Specialization
Citations

This map shows the geographic impact of Mark Gompels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gompels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gompels more than expected).

Fields of papers citing papers by Mark Gompels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gompels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gompels. The network helps show where Mark Gompels may publish in the future.

Co-authorship network of co-authors of Mark Gompels

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Gompels. A scholar is included among the top collaborators of Mark Gompels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Gompels. Mark Gompels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grigoriadou, Sofia, Smita Y. Patel, Leman Mutlu, et al.. (2024). Investigating pulmonary and non-infectious complications in common variable immunodeficiency disorders: a UK national multi-centre study. Frontiers in Immunology. 15. 1451813–1451813. 2 indexed citations
2.
Gompels, Mark, et al.. (2024). A patient with CVID-enteropathy successfully treated with ustekinumab. Immunologic Research. 73(1). 19–19. 2 indexed citations
3.
4.
Hart, Melanie, Mark Gompels, Alan Winston, et al.. (2023). Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial. Viruses. 16(1). 2–2.
5.
Grammatikos, Alexandros, et al.. (2020). Antibiotic prophylaxis for the prevention of respiratory tract infections in antibody deficient patients: A retrospective cohort study. Clinical Infection in Practice. 7-8. 100048–100048. 2 indexed citations
6.
Ibrahim, Fowzia, Lucy Campbell, Sarah Stockwell, et al.. (2020). Estimated glomerular filtration rate slopes on tenofovir alafenamide. HIV Medicine. 21(9). 607–612. 11 indexed citations
7.
8.
9.
Gompels, Mark, et al.. (2019). Trends in HIV testing in the UK primary care setting: a 15-year retrospective cohort study from 2000 to 2015. BMJ Open. 9(11). e027744–e027744. 5 indexed citations
10.
Gompels, Mark, et al.. (2017). Benchmarked performance charts using principal components analysis to improve the effectiveness of feedback for audit data in HIV care. BMC Health Services Research. 17(1). 506–506. 2 indexed citations
11.
Gatell, José M., Lambert Assoumou, Graeme Moyle, et al.. (2017). Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk. AIDS. 31(18). 2503–2514. 54 indexed citations
12.
José, Sophie, Killian Quinn, Teresa Hill, et al.. (2014). Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy. AIDS. 28(9). 1333–1339. 8 indexed citations
13.
Sabin, Caroline, Valérie Delpech, Teresa Hill, et al.. (2010). Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations*. HIV Medicine. 11(7). 432–438. 30 indexed citations
14.
Leen, Clifford, Jonathan Ainsworth, J. Anderson, et al.. (2009). Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? United Kingdom Collaborative HIV Cohort Study Group. UCL Discovery (University College London). 7 indexed citations
15.
Bower, Mark, Martin Fisher, Tetiana Hill, et al.. (2009). CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK. Haematologica. 94(6). 875–880. 45 indexed citations
16.
Gompels, Mark, et al.. (2005). C1 inhibitor deficiency: management. Clinical and Experimental Dermatology. 30(6). 737–740. 6 indexed citations
17.
Gompels, Mark, et al.. (2002). Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant: Figure 1. Journal of Clinical Pathology. 55(10). 784–786. 27 indexed citations
18.
Johnston, Sarah, R J Lock, & Mark Gompels. (2002). Takayasu arteritis: a review. Journal of Clinical Pathology. 55(7). 481–486. 451 indexed citations
19.
Bethune, Claire, Mark Gompels, & Gavin P Spickett. (1999). Lesson of the week: Physiological effects of starvation interpreted as food allergy. BMJ. 319(7205). 304–305. 4 indexed citations
20.
James, Nicholas D., R J Coker, David R. Tomlinson, et al.. (1994). Liposomal doxorubicin (Doxil): An effective new treatment for Kaposi's sarcoma in AIDS. Clinical Oncology. 6(5). 294–296. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David M. Aboulafia Breakdown of academic impact, for papers by A J Pinching Breakdown of academic impact, for papers by Aman Sharma Breakdown of academic impact, for papers by Joseph A. Church Breakdown of academic impact, for papers by A Sobel Breakdown of academic impact, for papers by Tim Niehues Breakdown of academic impact, for papers by Robert P. Nelson Breakdown of academic impact, for papers by A Levine Breakdown of academic impact, for papers by Maëlenn Gouillou Breakdown of academic impact, for papers by Aziza Shad
Rankless by CCL
2026